Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 6/2022

16-09-2021 | Ulcerative Colitis | Editorial

Impatience with Inpatients: Are Hospitalization Rates Declining for IBD Patients?

Authors: Anand Kumar, Arun Swaminath

Published in: Digestive Diseases and Sciences | Issue 6/2022

Login to get access

Excerpt

The annual costs of inflammatory bowel disease (IBD) care exceed $14 billion in the United States alone, of which hospitalization-related expenditure accounts for nearly two thirds of the cost [1]. The rising incidence and prevalence of IBD places an even greater stress on health care systems. Evaluation of current and past IBD hospitalization and readmission trends will help develop policies necessary to address the challenges faced by health systems in providing high-quality and cost-effective care for this patient population. …
Literature
1.
Mehta F. Report: economic implications of inflammatory bowel disease and its management. Am J Manag Care. 2016;22:s51-60.PubMed
2.
Turner D, Ricciuto A, Lewis A et al. STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160:1570–1583.CrossRef
3.
Colombel JF, Narula N, Peyrin-Biroulet L. Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology 2017;152:351-361e55.CrossRef
4.
Tsai L, Nguyen NH, Ma C, Prokop LJ, Sandborn WJ, Sing S. Systematic Review and Meta-analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn’s Disease in Population-based Cohort Studies. Dig Dis Sci. (Epub ahead of print). https://​doi.​org/​10.​1007/​s10620-021-07200-1.
5.
Niewiadomski O, Studd C, Hair C et al. Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity. J Gastroenterol Hepatol 2015;30:1346–1353.CrossRef
6.
Verdon C, Reinglas J, Coulombe J et al. No change in surgical and hospitalization trends despite higher exposure to anti-tumor necrosis factor in inflammatory bowel disease in the québec provincial database from 1996 to 2015. Inflamm Bowel Dis 2021;27:655–661.CrossRef
7.
Samuel S, Ingle SB, Dhillon S et al. Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis. Inflamm Bowel Dis 2013;19:1858–1866.PubMed
8.
Gajendran M, Umapathy C, Loganathan P, Hashash JG, Koutroubakis IE, Binion DG. Analysis of hospital-based emergency department visits for inflammatory bowel disease in the USA. Dig Dis Sci 2016;61:389–399.CrossRef
9.
Jeuring SF, van den Heuvel TR, Liu LY et al. Improvements in the long-term outcome of Crohn’s disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL Cohort. Am J Gastroenterol 2017;112:325–336.CrossRef
10.
Jeuring SF, Bours PH, Zeegers MP et al. Disease outcome of ulcerative colitis in an era of changing treatment strategies: results from the Dutch population-based IBDSL Cohort. J Crohns Colitis. 2015;9:837–845.CrossRef
11.
Burisch J, Katsanos KH, Christodoulou DK et al. Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception Cohort-An Epi-IBD study. J Crohns Colitis. 2019;13:198–208.CrossRef
12.
Nocerino A, Feathers A, Ivanina E, Durbin L, Swaminath A. Mortality risk of inflammatory bowel disease: a case-control study of New York state death records. Dig Dis Sci 2019;64:1604–1611.CrossRef
Metadata
Title
Impatience with Inpatients: Are Hospitalization Rates Declining for IBD Patients?
Authors
Anand Kumar
Arun Swaminath
Publication date
16-09-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07241-6

Other articles of this Issue 6/2022

Digestive Diseases and Sciences 6/2022 Go to the issue

Original Article

Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy

DDS Author Profiles

Author Spotlight: Damien Bouriez

Original Article

A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease

Stanford Multidisciplinary Seminars

Making It Stick: Management of Gastroesophageal Junction Adenocarcinoma with Poorly-Cohesive Cells (PCC)

Concise Commentary

Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients

Original Article

Bile Acid Malabsorption in Patients with Neuroendocrine Tumors
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits